跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,273 条关于
“AXN-27M”
全部
19,273
临床试验
18,149
药物
632
机构
22
资讯
470
8个月前
Instil Bio Terminates Licensing Agreement and Discontinues Lead Cancer Drug Development
去年
Instil Bio's PD-L1xVEGF Bispecific Antibody Shows Promise in NSCLC, Driving 48% Stock Surge
去年
Instil Bio and ImmuneOnco Advance PD-(L)1xVEGF Bispecific Antibody Clinical Development Strategy
去年
Instil Bio Appoints Veteran Oncologist Jamie Freedman as Chief Medical Officer to Advance PD-L1xVEGF Bispecific
去年
ARPA-H Awards $27M to Phare Bio for AI-Powered Antibiotic Discovery Platform
3个月前
Ember LifeSciences Secures $27M Series A Funding to Advance Cold Chain Technology for Pharmaceutical Distribution
去年
EG 427 Secures €27M Series B to Advance Novel Gene Therapy for Spinal Cord Injury-Related Bladder Dysfunction
去年
Auron Therapeutics Secures FDA Clearance for Novel Cancer Drug AUTX-703 and $27M Series B Funding
3个月前
Pramaana Labs Raises $27M to Bring Formal Verification to AI in Drug Discovery and Medical Diagnosis
去年
Great Southern Copper Reports High-Grade Cu-Ag Results from Mostaza Mine Drilling
第 1 页,共 47 页
上一页
下一页